Answers are grounded in this paper and cite their sources.
Prospective trial finds fingerstick blood tests effectively detect HCV RNA in at-risk individuals, suggesting wider use can be beneficial.
Data from this clinical trial showed that the Xpert® HCV test was sensitive, specific, and acceptable for use to detect HCV RNA in human EDTA fingerstick blood from individuals at risk and/or with signs/symptoms of HCV infection.
No takes yet. Share an insight, caveat, or question.
Havens et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: